References

Eat Sleep Burn

Best Weight Loss Programs That Work

Get Instant Access

1. Filipe MI. Mucins in the gastrointestinal epithelium: a review. Invest. Cell Pathol. 1979; 2:195-216.

2. Ehsanullah M, Filipe MI, Gazzard B. Mucin secretion in inflammatory bowel disease; correlation with disease activity and dysplasia. Gut 1982; 23:485-489.

3. Rhodes JM, Gallimore R, Elias E, Kennedy JF. Faecal sulphatase in health and in inflammatory bowel disease. Gut 1985; 26:466-469.

4. Kvietys PR, Granger DN. Regulation of colonic blood flow. Fed. Proc. 1982; 41:21002110.

5. Grandison AS, Yatres J, Shields R. Capillary blood flow in the canine colon and other organs at normal and raised portal pressure. Gut 1981; 22:223-227.

6. Glick ME, Meshkinpour H, Haldeman S, Bhatia NN, Bradley WE. Colonic dysfunction in multiple sclerosis. Gastroenterol. 1982; 83:1002-1007.

7. Braaten B, Madara JL, Donowitz M. Age related loss of non-goblet cells parallels decreased secretion in rat descending colon. Am. J. Physiol. 1988; 255:G72-G84.

8. Debongie JC, Phillips SF. Capacity of the human colon to absorb fluid. Gastroenterol. 1978; 74:698-703.

9. Palma R, Vidon N, Bernier JJ. Maximal capacity for fluid absorption in human bowel. Dig. Dis. Sci. 1981; 26:929-934.

10. Evans DF, Pye G, Bramley R, Clark AG, Dyson TJ, Hardcastle JD. Measurement of gastrointestinal pH profiles in normal, ambulant human subjects. Gut 1988; 29:10351041.

11. Gilbert J, Kelleher J, Littlewood JM, Evans DG. Ileal pH in cystic fibrosis. Scand. J. Gastroenterol. 1988; 23 (Suppl. 43):132-134.

12. Spiller RC, Brown ML, Phillips SF. Decreased fluid tolerance, accelerated transit and abnormal motility of the human colon induced by oleic acid. Gastroenterol. 1986; 91:100-107.

13. Granger DN, Barrowman JA, Kvietys PR. Clinical Gastrointestinal Physiology. W.B.Saunders Company, Philadelphia 1985.

14. Christensen J, Caprilli R, Lund GF. Electrical slow waves in the circular muscle of cat colon. Am. J. Physiol. 1969; 217:771-776.

15. Christensen J, Anuras S, Hauser RL. Migrating spike bursts and electrical slow waves in the cat colon: effect of sectioning. Gastroenterol. 1974; 66:240-247.

16. Christensen J, Hauser RL. Longitudiinal axial coupling of slow waves in the proximal cat colon. Am. J. Physiol. 1971; 221:246-250.

17. Devroede G, Soffie M. Colonic absorption in ideopathic constipation. Gastroenterol. 1973; 64:552-561.

18. Holdstock DJ, Misiewicz JJ. Factors controlling colonic motility: Colonic pressures and transit after meals in patients with total colonic gastrectomy, pernicious anaemia and duodenal ulcer. Gut 1970; 11:100-110.

19. Wright RA, Snape WJ, Battle W, Cohen S, London RL. Effect of dietary components on the gastrocolic response. Am. J. Physiol. 1980; 238:G228-G232.

20. Sun EA, Snape WJ, Cohen S, Renny A. The role of opiate receptors and cholinergic neurones in the gastrocolic response. Gostroenterol. 1982; 82:689-693.

21. Tansy MF, Kendell CsFM. Experimental and clinical aspects of gastrocolic reflexes. Am. J. Dig. Dis. 1973; 18:521-531.

22. Snape Jr WJ, Matarazzo SA, Cohen S. Effect of eating and gastrointestinal hormones on human colonic myoelectrical and colon activity. Gastroenterol. 1978; 75:373-378.

23. Vizi SE, Ono K, Adam-Vizi V, Duncalf D, Foldes FF. Presynatic inhibitory effect of met enkephalin on [14C] acetylcholine release from the myenteric plexus and its interaction with muscarinic negative feedback inhibition. J. Pharmacol. Exp. Ther. 1984; 230:493499.

24. Jian R, Najean Y, Bernier JJ. Measurement of intestinal progression of a meal and its residues in normal subjects and patients with functional diarrhoea by a dual isotope technique. Gut 1984; 25:728-731.

25. Moreno-Osset E, Bazzocchi G, Lo S, Trombley B, Ristow E, Reddy SN, et al. Association between postprandial changes in colonic intraluminal pressure and transit. Gastroenterol. 1989; 96:1265-1273.

26. Bassotti G, Betti C, Imbimbio BP, Pelli MA, Morelli A. Colonic motor response to eating: A manometric investigation in proximal and distal portions of the viscus in man. Am. J. Gastroenterol. 1989; 84:118-122.

27. Lubowski DZ, Meagher AP, Smart RC, Butler SP. Scintigraphic assessment of colonic function during defecation. Int. J. Colorect. Dis. 1995; 10:91-93.

28. Davies GJ, Growder M, Reid B, Dickerson JWT. Bowel function measurements of individuals with different eating patterns. Gut 1986; 27:164-169.

29. Arhan P, Devroede G, Jehannin B, et a. Segmental colonic transit time. Dis. Colon Rectum 1981; 24:625-629.

30. Wyman JB, Heaton KW, Manning AP. Variability of colonic function in healthy subjects. Gut 1978; 19:146-150.

31. Metcalf AM, Phillips SF, Zinsmeister AR, MacCarty RL, Beart RW, Wolff BG. Simplified assessment of segmental colonic transit. Gastroenterol. 1987; 92:40-47.

32. Abrahamsson H, Antov S, Bosaeus I. Gastrointestinal and colonic segmental transit time evaluated by a single abdominal x-ray in healthy subjects and constipated patients. Scand. J. Gastroenterol. 1988; 23:72-80.

33. Hinds JP, Stoney B, Wald A. Does gender or the menstrual cycle affect colonic transit? Am. J. Gastroenterol. 1989; 84:123-126.

34. Stephen AM, Wiggins HS, Englyst HN. The effect of age, sex and level of intake of dietary fibre from wheat on large-bowel function in thirty healthy subjects. Br. J. Nutr. 1986; 56:349-361.

35. Narducci F, Snape WJ, Battle WM, London RL, Cohen S. Increased colonic motility during exposure to a stressful situation. Dig. Dis. Sci. 1985; 30:40-44.

36. Keeling WF, Martin BJ. Gastrointestinal transit during mild exercise. J. Appl. Physiol. 1987; 63:978-981.

37. Oettle GJ. Effect of moderate exercise on bowel habit. Gut 1991; 32:941-944.

38. Hinton JM, Lennard-Jones JE, Young AC. A new method for studying gut transit times using radio-opaque markers. Gut 1969; 10:847-857.

39. Kirwan WO, Smith AN. Gastrointestinal transit estimated by an isotope capsule. Scand. J. Gastroenterol. 1974; 9:763-766.

40. Cummings JH, Branch W, Jenkins DJA, Southgate DAT, Houston H, James WPT. Colonic response to dietary fibre from carrot, cabbage, apple, bran and guar gum. Lancet 1978; 1:5-9.

41. Tomlin J, Read NW. Comparison of the effects on colonic function caused by feeding rice bran and wheat bran. Eur. J. Clin. Nutr. 1988; 42:857-861.

Tomlin J, Read NW. The relation between bacterial degradation of viscous polysaccharides and stool output in human beings. Br. J. Nutr. 1988; 60:467-475. Barrow L, Steed KP, Watts PJ, Melia CD, Davies MC, Wilson CG, et al. Scintigraphic demonstration of lactulose-induced accelerated proximal colon transit. Gastroenterol. 1991; 103:1167-1175.

Janne P, Carpenter Y, Willems G. Colonic mucosal atrophy induced by a liquid elemental diet in rats. Am. J. Dig. Dis. 1977; 22:808-812.

Goodlad RA, Wright NA. The effects of the addition of cellulose or kaolin to an elemental diet on intestinal cell proliferation in the mouse. Br. J. Nutr. 1983; 50:91-98. Goodlad RA, Lenton W, Ghatei MA, Bloom SR, Wright NA. Effects of an elemental diet, inert bulk and different types of dietary fibre on the response of the intestinal epithelium to refeeding in the rat and the relationship to plasma gastrin, enteroglucagon and PYY levels. Gut 1987; 28:171-180.

Findlay JM, Smith AN, Mitchell WD, Anderson AJD, Eastwood MA. Effects of unprocessed bran on colonic function in normal subjects and in diverticular disease. Lancet 1974; i(7849):146-149.

Kirwan WO, Smith AN, McConnell AA, Mitchell WD, Eastwood MA. Action of different bran preparations on colonic function. Br. Med. J. 1974; 4:187-189. Fich A, Phillips SF, Hakim NS, Brown ML, Zinsmeister AR. Stimulation of ileal emptying by short-chain fatty acids. Dig. Dis. Sci. 1989; 34:1516-1520. Pye G, Crompton J, Evans DF, Clarke AG, Hardcastle JD. Effect of dietary fibre supplementation on colonic pH in healthy individuals (abstract). Gut 1987:A1328. Brown SR, Cann PA, Read NW. Effect of coffee on distal colon function. Gut 1990; 31:450-453.

Stephen AM, Wiggins HS, Cummings JH. Effect of changing transit time on colonic microbial metabolism in man. Gut 1987; 28:601-609.

O'Brien JD, Thompson DG, McIntyre A, Burnham WR, Walker E. Effect of codeine and loperamide on upper intestinal transit and absorption in normal subjects and patients with postvagotomy diarrhoea. Gut 1988; 29:312-318.

Schiller LR, Davis GR, Santa Ana CA, Morawski SG, Fordtran JS. Studies of the mechanism of the antidiarrheal effect of codeine. J. Clin. Invest. 1982; 70:999-1008. Schiller LR, Santa Ana CA, Morawski SG, Fordtran JS. Mechanism of the antidiarrheal effect of loperamide. Gastroenterol. 1984; 86:1475-1480.

Kaufman PN, Krevsky B, Malmud LS, Maurer AH, Somers MB, Siegel JA, et al. Role of opiate receptors in the regulation of colonic transit. Gastroenterol. 1988; 94:13511356.

Kamath PS, Phillips SF, O'Connor MK, Brown ML, Zinsmeister AR. Colonic capacitance and transit in man: modulation by luminal contents and drugs. Gut 1990; 31:443-449.

Krevsky B, Libster B, Maurer AH, Chase BJ, Fisher RS. Effects of morphine and naloxone on feline colonic transit. Life Sciences 1989; 44:873-879. Konturek JW, Konrurek SJ, Kurek A, Bogdal J, Olesky J, Rovati L. CCK receptor antagonism by loxiglumide and gall bladder contractions in response to cholecystokinin, sham feeding and ordinary feeding in man. Gut 1989; 30:1136-1142. Corazziari E, Ricci R, Biliotti D, Bontempo I, De'Medici A, Pallotta N, et al. Oral administration of loxiglumide (CCK antagonist) inhibits postprandial gallbladder contraction without affecting gastric emptying. Dig. Dis. Sci. 1990; 35:50-54. Meyer BM, Werth BA, Beglinger C, Hildebrand P, Jansen J, Zach D, et al. Role of cholecystokinin in regulation of gastrointestinal motor functions. Lancet 1989; 2(8653):12-15.

Mackay M, J.P, J.H. Peptide drug delivery: Colonic and rectal absorption. Adv. Drug Deliv. Rev. 1997; 28:253-273.

Schanker LS. Absorption of drugs from the rat colon. J. Pharmacol. 1959; 126:283290.

Slade L, Bishop R, Morris JG, Robinson DW. Digestion and absorption of 15N labelled microbial protein in the large intestine of the horse. Br. J. Vet. 1971; 11:127-130.

65. Kathpalia SC, Favus MJ, Coe JL. Evidence for the size and charge permselectivity of rat ascending colon. Effect of ricinoleate and bile salts on oxalic acid and neutral sugar transport. J. Clin. Invest. 1984; 74:805-811.

66. Fordtran JS, Restor FC, Ewton MF, Soter N, Kinney J. Permeability characteristics in the human small intestine. J. Clin. Invest. 1965; 44:1935-1944.

67. McNeil NI, Ling KLE, Wager J. Mucosal surface pH of the large intestine of the rat and of normal and inflammed large intestine in man. Gut 1987; 28:707-713.

68. Johnson IT, Gee JM. Effect of gel forming food gums on the intestinal unstirred layer and sugar transport in vitro. Gut 1981; 22:398-403.

69. Staib AH, Beermann D, Harder S, Fuhr U, Liermann D. Absorption differences of ciprofloxacin along the human gastrointestinal tract determined using a remote-control drug delivery device (HF-capsule). Am. J. Med. 1989; 87:66S-69S.

70. Bassotti G, Gaburri M. Manometric investigation of high-amplitude propagated contractile activity of the human colon. Am. J. Physiol. 1988; 255:G660-G664.

71. Bassotti G, Betti C, Fusaro C, Morelli A. Colonic high-amplitude propagated contractions (mass movements): repeated 24-h manometric studies in healthy volunteers. J. Gastrointest. Mot. 1992; 4:187-191.

72. Narducci F, Bassotti G, Gaburri M, Morelli A. Twenty four hour manometric recording of co-Ionic motor activity in healthy man. Gut 1987; 28:17-25.

73. Frexinos J, Bueno L, Fioramonti J. Diurnal changes in myoelectrical spiking activity of the human colon. Gastroenterol. 1985; 88:1104-1110.

74. Steadman CJ, Phillips SF, Camilleri M, Haddad AC, Hanson RB. Variation of muscle tone in the human colon. Gastroenterol. 1991; 101:373-381.

75. Parker G, Wilson CG, Hardy JG. The effect of capsule size and density on the transit through the proximal colon. J. Pharm. Pharmacol. 1988; 40:376-377.

76. Hardy JG, Wilson CG, Wood E. Drug delivery to the proximal colon. J. Pharm. Pharmacol. 1985; 37:874-877.

77. Proano M, Camilleri M, Phillips SF, Brown ML, Thomforde GM. Transit of solids through the human colon: regional quantification in the unprepared bowel. Am. J. Physiol. 1990; 258:G856- G862.

78. Barrow L, Steed KP, Spiller RC, Maskell NA, Brown JK, Watts PJ. Quantitative, noninvasive assessment of antidiarrheal actions of codeine using an experimental model of diarrhea in man. Dig. Dis. Sci. 1993; 38:996-1003.

79. Watts PJ, Barrow L, Steed KP, Wilson CG, Spiller RC, Melia CD. The transit rate of different-sized model dosage forms through the human colon and the effects of a lactulose-induced catharsis. Int. J. Pharmaceut. 1992; 87:215-2.

80. Halls J. Bowel shift during normal defaecation. Proc. Roy. Soc. Med. 1965; 58:859860.

81. Cummings JH. Constipation, dietary fibre and the control of large bowel function. Postgrad. Med. J. 1984; 60:811-819.

82. Hardy JG, Lee SW, Clark AG, Raynolds JR. Enema volume and spreading. Int. J. Pharmaceut. 1986; 31:151-155.

83. Healey JNC. Enteric coatings and delayed release. In: Drug Delivery to the Gastrointestinal Tract, Hardy, J.G., Davis, S.S., Wilson, C.G. (eds) Ellis Horwood, Chichester 1989; Chapter 7:83-96.

84. Dew MJ, Hughes PJ, Lee MG, Evans BK, Rhodes J. An oral preparation to release drugs in the human colon. Br. J. Clin. Pharmacol. 1982; 14:405-408.

85. Wilson CG, Bakhashaee M, Stevens HNE, Perkins AC, Frier M, Blackshaw PE, et al. An evaluation of a gastro-resistant pulsed release delivery system (Pulsincap) in man. Drug Delivery 1997; 4:201-206.

86. Sangalli ME, Maroni A, Busetti C, Zema L, Giordano F, Gazzaniga A. In vitro and in vivo evaluation of oral systems for time and site specific delivery of drugs (Chronotopic technology). Bollettino Chimico Farmaceutico 1999; 138:68-73.

87. Duchene D, Ponchel G. Colonic administration, development of drug delivery systems, contribution of bioadhesion. STP Pharma Sciences 1993; 3:277-285.

88. Rubinstein A. Microbially controlled drug delivery to the colon. Biopharm. Drug Disposition 1990; 11:465-487.

89. Van Den Mooter G, Samyn C, Kinget R. Azo polymers for colon-specific drug delivery. Int. J.Pharmaceut. 1992; 87:37-46.

90. Khan M, Prebeg Z, Kurjakovic N. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation Of drug release using Eudragit L100-55 and Eudragit S100 combinations. J. Cont. Rel. 1999; 58:215-222.

91. Dew MJ, Ryder REJ, Evans N, Evans N, Rhodes J. Colonic release of 5-aminosalicylic acid from an oral preparation in active ulcerative colitis. Br. J. Clin. Pharmacol. 1983; 16:185-187.

92. Ashford M, Fell JT, Attwood D, Sharma HL, Woodhead PJ. Colonic drug delivery via the use of pH dependent polymers (abstract). J. Pharm. Pharmacol. (Suppl.) 1991; 43:60.

93. Chiu HC, Hsiue GH, Lee YP, Huang LW. Synthesis and characterization of pH-sensitive dextran hydrogels as a potential colon-specific drug delivery system. J. Biomater. Sci., Polymer Edition 1999; 10:591-608.

94. Brondsted H, Andersen C, Hovgaard L. Crosslinked dextran—a new capsule material for colon targeting of drugs. J. Cont. Rel. 1998; 53:7-13.

95. Rashid A. Dispensing Device. British Patent Application 1990; 2230441A:15 February, 1990.

96. Kilpatrick DC, Pusztai A, Grant G, Graham C, Ewen SWB. Tomato lectins resists digestion in the mammalian alimentary canal and binds to intestinal villi without deleterious effects. FEBS letters 1985; 185:299-305.

97. Schacht E, Gevaert A, Kenawy ER, Molly K, Verstraete W, Adriaensens P, et al. Polymers for colon specific drug delivery. JJ. Cont. Rel. 1996; 39:327-338.

98. Van Den Mooter G, Offringa M, Kalala W, Samyn C, Kinget R. Synthesis and evaluation of new linear azo-polymers for colonic targeting. S.T.P. Pharma Sciences 1995; 5:36-40.

99. Saffran M, Kumar GS, Savariar C, Burnham GS, Williams F, Neckers DC. A new approach to the oral administration of insulin and other peptide drugs. Science 1986; 233(4768):1081-1084.

100. Friend DR. Glycoside prodrugs: Novel pharmacotherapy for colonic diseases. S.T.P. Pharma Sciences 1995; 5:70-76.

101. Krishnaiah YS, Satyanarayana S, Rama Prasad YV, Narasimha Rao S. Gamma scintigraphic studies on guar gum matrix tablets for colonic drug delivery in healthy human volunteers. J. Cont. Rel. 1998; 55:245-252.

102. Krishnaiah YS, Satyanarayana S, Prasad YV. Studies of guar gum compression-coated 5-aminosalicylic acid tablets for colon-specific drug delivery. Drug Develop. Indust. Pharm. 1999; 25:651-657.

103. Bauer KH, Kesselhut JF. Novel pharmaceutical excipients for colon targeting. S.T.P. Pharma Sci. 1995; 5:54-59.

104. Uekama K, Minami K, Hirayama F. 6A-O-[(4-biphenylyl)acetyl]-alpha-, -beta-, and -gamma-cyclodextrins and 6A-deoxy-6A-[[(4-biphenylyl)acetyl]amino]-alpha-, -beta-, and -gamma-cyclodextrins: potential prodrugs for colon-specific delivery. J. Med. Chem. 1997; 40:2755-2761.

105. Ashford M, Fell J, Attwood D, Sharma H, Woodhead P. An evaluation of pectin as a carrier for drug targeting to the colon. J. Cont. Rel. 1993; 26:213-220.

106. Radai R, Rubinstein A. In vitro and in vivo analysis of colon specificity of calcium pectinate formulations. 1993:330-331.

107. Wakerly Z, Fell JT, Attwood D, Parkins D. Pectin/ethylcellulose film coating formulations for colonic drug delivery. Pharmaceut. Res. 1996; 13:1210-1212.

108. Rubinstein A, Radai R. In vitro and in vivo analysis of colon specificity of calcium pectinate formulations. Europ. J. Pharmaceut. Biopharmaceut. 1995; 41:291-295.

109. Magnusson JO, Bergdahl B, Bogentofot C, Jonsson UE. Metabolism of digoxin and absorptivesite . Br. J. Clin. Pharmacol. 1982; 14:284-285.

110. Olaison B, Sjodahl R, Leandersson P, Tagesson C. Abnormal intestinal permeability pattern in colonic Crohn's disease. Scand. J. Gastroenterol. 1989; 24:571-576.

111. Shaffer Saitt JL, Higham C, Turnberg LA. Hazards of slow release preparations in patients with bowel strictures. Lancet 1980; 30:2(8192):487.

112. Roberts JP, Newell MS, Decks JJ, Waldron DW, Garvie NW, Williams NS. Oral [In-Ill] DTPA scintigraphic assessment of colonic transit in constipated subjects. Dig. Dis. Sci 1993; 38:1032-1039.

113. De Boer AG. First-pass elimination of some high clearance drugs following rectal administration to humans and rats. PhD. Thesis, University of Leiden, The Netherlands. 1979.

114. De Boer AG, Breimer DD, Pronk FJ, Gubbens-Stibbe JM. Rectal bioavailability of lidocaine in rats: absence of significant first-pass elimination. J. Pharmaceut. Sci. 1980; 69:804-807.

115. Kleinbloesem CH, van Harten J, de Leede LGJ. Nifedipine kinetics and dynamics during rectal infusion to steadt state with an osmotic system. Clin. Pharmacol. Therapeut. 1984; 36:396-401.

116. Manning CD, Vickers AP, Smith G, Graham NB, McNeil ME. The morphine hydrogel suppository. Br. J. Anaesthesiol. 1988; 61:221-227.

117. Tukker J. Biopharmaceutics of fatty suspension suppositories: The influence of physiological and physical parameters of spreading and bioavailability in dog and man: PhD thesis, University of Leiden, The Netherlands. 1983.

118. Hardy JG, Feely LC, Wood E, Davis SS. The application of gamma-scintigraphy for the evaluation of the relative spreading of suppository bases on rectal hard gelatin capsules. Int. J. Pharmaceut. 1987; 38:103-108.

119. Sugito K, Ogata H, Noguchi M, Kogure T, Takano M, Maruyama Y, et al. The spreading of radiolabelled fatty suppository bases in the human rectum. Int. J. Pharmaceut. 1988; 47:157-162.

120. Vanbodegraven AA, Boer RO, Lourens J, Tuynman HARE, Sindram JW. Distribution of mesalazine enemas in active and quiescent ulcerative-colitis. Aliment. Pharmacol. Therapeut. 1996; 10:327-332.

121. Wood E, Wilson CG, Hardy JG. The spreading of foam and solution enemas. Int. J. Pharmaceut. 1985; 25:191-197.

122. Moolenaar F, Bakker S, Visser J, Huizinga T. Comparative biopharmaceutics of diazepam after single rectal, oral, intramuscular and intravenous administration in man. Int. J. Pharmaceut. 1980; 5:127-137.

123. Shrirai H, Miura H, Sunaoshi W. A clinical study on the effectiveness of intermittent therapy with rectal diazepam suppositories for the prevention of recurrent febrile convulsions and the development of epilepsy during the study period. Brain and Development 1988; 10:201-202.

124. Dhillon S, Oxley J, Richens A. Bioavailability of diazepam after intravenous, oral and rectal administration in adult epileptic patients. Br: J. Clin. Pharmacol. 1982; 13:427-432.

125. Milligan N, Dhillon S, Richens A, Oxley J. Absorption of diazepam from the rectum and its effect on interrictal spikes in the EEG. Epilepsia 1982; 23:323-331.

126. De Boer AG, Moolenaar F, de Leede LGJ, Breimer DD. Rectal drug administration: clinical pharmacokinetic considerations. Clin. Pharmacokinet. 1982; 7:285-311.

127. Graves NM, Kriel RL, Jones-Saete C, Cloyd JC. Relative bioavailability of rectally administered carbemazepine suspension in humans. Epilepsia 1985; 26:429-433.

128. Neuvonen PJ, Tokoia O. Bioavailability of rectally administered carbamazepine mixture. Br. J. Clin. Pharmacol. 1987; 24:839-841.

129. Saint-Maurice C, Meistelman C, Rey E, Esteve C, de Lauture D. The pharmacokinetics of rectal midazolam for premedication in children. Anaesthesiol. 1986; 65:536-538.

130. Clausen TG, Wolff J, Hansen PB, Larsen F, Rasmussen SN. Pharmacokinetics of midazolam and a-hydroxy-midazolam following rectal and intravenous administration. Br. J. Clin. Pharmacol. 1988; 25:457-463,

131. Ravnborg M, Hasselstrom L, 0stengard D. Premedication with oral and rectal diazepam. Acta Anaesthesiol. Scand. 1986; 30:132-138.

132. Lundgren S, Ekman A, Blomback U. Rectal administration of diazepam in solution. Swed. Dent. J. 1979; 2:161-166.

133. Kraus G, Frank S, Knoll R, Prestele H. pharmakokinetische Untersuchungen nach intravenoser, intermuskularar und rektaler. Applikation von Methohexital bei Kindern. Anaesthesist 1984; 33:266-271.

134. Jantzen JPAH, Erdmann K, Witton PK, Klein AM. Der Einfluss der rekalen pH-Wertes auf die Resorption von Methohexital. Anaesthesist 1986; 35:469-499.

135. Olsson GL, Bejersten A, Feychting H, Palmer L, Petterson B-M. Plasma concentrations of atropine after rectal administration. Anaesthesia 1983; 38:1179-1182.

136. Michel P, Benoit I, Grellet J, Saux MC, Hazane C. Evaluation pharmacocinétique en pédiatrie d'un gel rectale hydrophile de sulfate d'atropine. J. Pharmacie Clin. 1988; 7:419.

137. Moolenaar F, Yska JP, Visser J, Meijer DKF. Drastic improvement in the rectal absorption profile of morphine in man. Europ. J. Clin. Pharmacol 1985; 29:119-121.

138. Moolenaar F, Kauffmann BG, Visser J, Meijer DKF. Rectal absorption of methadone from dissolution-prmotong vehicles. Int. J. Pharmaceut. 1986; 33:249-252.

139. Moolenaar F, Grasmeijer G, Visser J, Meijer DKF. Rectal versus oral absorption of codeine phosphate in man. Biopharmaceut. Drug Disposit. 1986; 4:195-199.

140. Moolenaar F, Cox HLM. Rectaal absorptieprofiel van codeine vanuit zetpillen bereid met codeinefosfaat en acerylsalicylzuur. Pharm. Weekblad 1983; 118:818-821.

141. Nishihata T, Sudho M, Kamada A, Keigami M, Fujimoto T. Investigation of sustained-release suppository of sodium diclofenac in humans. Int. J. Pharmaceut. 1986; 33:181186.

142. Houin G, Barre J, Tillement JP. Absolute intramuscular, oral and rectal bioavailability of alizapride. J. Pharmaceut. Sa. 1984; 73:1450-1453.

143. De Leede LGJ, De Boer AG, Van Velzen SL, Breimer DD. Zero order rectal delivery of theophylline in man with an osmotic system. J. Pharmacokinet. Biopharmaceut. 1982; 10:525-527.

144. Lunell E, Andersson K-E, Borga O, Fagerstrom P-O. Absorption of enprofylline from the gastrointestinal tract in healthy subjects. Europ. J. Clin. Pharmacol. 1984; 27:329333.

145. Eckardt VF, Kanzler G, Remmele W. Anorectal ergotism: another cause of solitary rectal ulcers. Gastroenterol. 1986; 91:1123-1127.

146. Rotenberg A, Chauveinc L, Rault P, Rozenberg H, Nemeth J, Potet F. Lesions rectales secondaires a l'abus de suppositoires de dextropropoxyphene et paracetamol. Presse Medicale 1988; 17:1545-1551.

147. Lanthier P, Detry R, Debognie JC, Mahieu P, Vanheuverzwyn R. Lesions solitaires du rectum dues a des suppositoires associant acide acetylsalicylique et paracetamol. Gastroenterol. Cliniq. Biologiq. 1987; 11:250-253.

148. Reid AS, Thomas NW, Palin KJ, Gould PL. Formulation of fenbufen suppositories. I: quantitative histological assessment of the rectal mucosa of rates following treatment with suppository bases. Int. J. Pharmaceut. 1987; 40:181-185.

149. Van Hoogdalem EJ, Vermeij-Keers C, De Boer AG, Breimer DD. Topical effects of absorption enhancing agents on the rectal mucosa of rats in vivo. J. Pharmaceut. Sci. 1990; 79:866-870.

Was this article helpful?

0 0
Lose 10 Pounds Naturally

Lose 10 Pounds Naturally

Studies show obesity may soon overtake tobacco as the leading cause of death in America. Are you ready to drop those extra pounds you've been carrying around? Awesome. Let's start off with a couple positive don't. You don't need to jump on a diet craze and you don't need to start exercising for hours each day.

Get My Free Ebook


Post a comment